KOELIS Trinity® for Prostate Fusion
Biopsy System Enhances Diagnosis and Care
Prostate cancer is among the top 10 cancer types globally, accounting for 7.3% of all cancer cases in 2020 according to the International Agency for Research on Cancer (IARC).1 Yet, the majority of prostate biopsies are still performed as random biopsies, despite new prostate cancer guidelines that recommend the early use of multiparametric magnetic resonance imaging (mpMRI) before a prostate biopsy in both biopsy naïve patients and in patients with a prior negative biopsy for the detection of prostate cancer.2
Internal Server Error
The server encountered an internal error or misconfiguration and was unable to complete your request.
Error has been logged.